 AUSTIN, Texas, July 20, 2021 PRNewswire -- Natera, Inc. Nasdaq: NTRA Natera, a pioneer and global leader in cell-free DNA testing, today announced the launch of a proposed follow-on public offering of 350,000,000 of shares of its common stock. In addition, Natera expects to grant the underwriters a 30-day option to purchase up to an additional 52,500,000 of shares of its common stock from Natera at the public offering price less the underwriting discounts and commissions. 